We're Moving to Revvity.com
Visitors from the United States and Canada can now explore, discover, and buy our products and services at Revvity.com. You will be automatically redirected to Revvity.com
Not located in the United States or Canada?
Revvity's Website is Moving! Revvity's Website is Moving! Explore solutions, set up your online account & more.
關於Revvity-- 以科技之能,突破人類潛能的邊界
(Revvity的前身是隸屬於爱游戏登录网 )
兩家獨立企業由此誕生
生命科學與診斷 & 分析和企業服務
We're Moving to Revvity.com
Visitors from the United States and Canada can now explore, discover, and buy our products and services at Revvity.com. You will be automatically redirected to Revvity.com
Not located in the United States or Canada?
排序方式
1-25 的 10751 產品與服務
其獨特的三組四極杆設計,結合新穎成熟的技術(包括第二代帶OmniRing™的三錐接口),可為用戶提供卓越的靈敏度、幹擾消除、穩定性、基質耐受性、通量/正常運行時間,以及可持續性和運營成本效率。
For more than twenty years, our EnVision plate reader has been the proven leader in high-throughput screening - and the EnVision® Nexus™ is the next generation of superior detection. It operates on a brand-new innovative platform that fast tracks your research, delivering the speed and accuracy you need for your most demanding applications. The EnVision Nexus multimode plate reader continues to deliver optimal results from our Alpha, HTRF®, LANCE®, and DELFIA® assay technologies.
Currently, automated methods are available for NEXTFLEX®, Illumina®, and Roche® KAPA® kits.
醫療器械注冊證:蘇械注準 20192220283
廣審號:待更新
禁忌內容或注意事項詳見說明書
醫療器械注冊證:蘇械注準20172411510
廣審號:待更新
禁忌內容或注意事項詳見說明書
The OMNI Prep 96 is a fully automated, high-throughput homogenizer workstation which enables true walk away sample processing in your lab.
醫療器械注冊證:蘇械注準20192400293
廣審號:待更新
禁忌內容或注意事項詳見說明書
醫療器械注冊證:
廣審號:待更新
禁忌內容或注意事項詳見說明書
感染性疾病是急診科常見的疾病之一,由感染引起的全身炎症反應綜合征是膿毒症最根本的病理生理學改變。由於全身炎症反應的複雜性,至今尚無理想的診斷、分層、預後工具和效果顯著的治療方案。
爱游戏登录网 感染及炎症標誌物檢測產品包含:
降鈣素原(PCT)- 蘇械注準20182401520
C-反應蛋白( CRP) - 蘇械注準20182401519
白細胞介素-6(IL-6)- 蘇械注準20222400961
廣審號:待更新
禁忌內容或注意事項詳見說明書
廣審號:待更新
禁忌內容或注意事項詳見說明書
醫療器械注冊證:國械注準20173404077
廣審號:待更新
禁忌內容或注意事項詳見說明書
醫療器械注冊證:國械注準20153400403
廣審號:待更新
禁忌內容或注意事項詳見說明書
醫療器械注冊證:蘇械注準20202220565
廣審號:待更新
禁忌內容或注意事項詳見說明書